Recent Updates
Recently added Catalysts

3M CHG/IPA Surgical Skin Preparation- Abdominal Region

Phase 2

Bacterial Recovery of Skin Flora Post-Product Application | Small molecule | Dermatology |Solventum Corporation|Last Updated: Oct 2, 2024

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedPLACEBO_CONTROLLED
Total Trials2
Total Enrollment96

FDA Designations

No designations recorded

Clinical trial landscape

3M CHG/IPA Surgical Skin Preparation- Abdominal Region · 3 trials · 3 indications

Phase 2 3
NCT03681990In Vivo Preoperative Skin Preparation Efficacy Study Within a Defined Product Coverage AreaSurgical Skin Preparation
COMPLETED28 Analytics
NCT03155178In Vivo Preoperative Skin Preparation Persistence EvaluationBacterial Recovery of Skin Flora Post-product Application
COMPLETED69 Analytics
NCT02447497In Vivo Patient Preoperative Skin Prep PersistenceBacterial Recovery of Skin Flora Post-Product Application
COMPLETED27 Analytics
PHASE2COMPLETED
In Vivo Preoperative Skin Preparation Efficacy Study Within a Defined Product Coverage Area
Surgical Skin PreparationUnlock trial analytics
PHASE2COMPLETED
In Vivo Preoperative Skin Preparation Persistence Evaluation
Bacterial Recovery of Skin Flora Post-product ApplicationUnlock trial analytics
PHASE2COMPLETED
In Vivo Patient Preoperative Skin Prep Persistence
Bacterial Recovery of Skin Flora Post-Product ApplicationUnlock trial analytics

Study Endpoints

Primary Endpoints

Comparison of Log Change of Skin Flora Relative to Pre-treatment (Baseline) in Each of 3 Sampling Sites at a Defined Post-treatment Sampling Time.
Post-treatment sampling randomized as 10-minute or 13-minute post-product application

The primary measure of efficacy is change in skin flora log10 CFU/cm\^2 in each of the skin sampling sites relative to baseline skin flora log10 CFU/cm\^2. Baseline samples must satisfy the greater than or equal to 3.0 in each of the sampling sites, to be used for data analysis.

Measurement of Skin Flora Recovery Post-prep Application
Baseline, 48-hours post-treatment, 72-hours post-treatment and 96-hours post-treatment

The primary measure of persistence is the suppression of regrowth recovery relative to baseline (log10 CFU/cm\^2) of skin flora at 3 defined post-treatment sampling times.

Measurement of Skin Flora Recovery Post-prep Application Relative to Baseline
Baseline, 48 hours and 72 hours post-prep application

The primary measure of persistence is the suppression of regrowth recovery relative to baseline (log10 CFU/cm\^2) of skin flora at two defined post-prep sampling times relative to baseline.

Secondary Endpoints

Change in Skin Flora Relative to 10 Minutes Post-prep Application
10-minute post-treatment, 48-hours post-treatment, 72-hours post-treatment and 96-hours post-treatment
Safety as Assessed by Skin Irritation Scores Coded by Study Staff
48 hours and 72 hours post-product application
Safety as Assessed by Adverse Events
To 72 hours post treatment
Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingNONE
ModelSINGLE_GROUP
PurposePREVENTION

Treatment Arms

ArmTypeDescription
3M CHG/IPA Prep / CenterEXPERIMENTALChlorhexidine gluconate (CHG) 2% / Isopropyl alcohol (IPA) 70% solution applied topically to intact skin; sample collected from center test site on skin in application area.
3M CHG/IPA Prep / Mid-peripheralEXPERIMENTALChlorhexidine gluconate (CHG) 2% / Isopropyl alcohol (IPA) 70% solution applied topically to intact skin; sample collected from mid-peripheral test site on skin in application area.
3M CHG/IPA Prep / PeripheralEXPERIMENTALChlorhexidine gluconate (CHG) 2% / Isopropyl alcohol (IPA) 70% solution applied topically to intact skin; sample collected from peripheral test site on skin in application area.
3M CHG/IPA PrepEXPERIMENTALApply topically for 30 seconds (abdominal site) or 2 minutes (inguinal site), and allow to dry for 3 minutes.
ChloraPrepACTIVE_COMPARATORApply topically for 30 seconds (abdominal site) or 2 minutes (inguinal site), and allow to dry for 3 minutes.
3M CHG/IPA - Abdominal RegionEXPERIMENTALApply Chlorhexidine (CHG) 2% / Isopropyl alcohol (IPA) 70% for 30 seconds and allow to dry for 3 minutes.
Normal Saline - Abdominal RegionPLACEBO_COMPARATORApply 0.9% sodium chloride with applicator for 30 seconds and allow to dry for 3 minutes.
3M CHG/IPA - Inguinal RegionEXPERIMENTALApply Chlorhexidine (CHG) 2% / Isopropyl alcohol (IPA) 70% for 30 seconds and allow to dry for 3 minutes.
Normal Saline - Inguinal RegionPLACEBO_COMPARATORApply 0.9% sodium chloride with applicator for 30 seconds and allow to dry for 3 minutes.

Interventions

NameTypeDescription
3M CHG/IPA PrepDRUGApply topically to intact skin
ChloraPrepDRUGApply topically to intact dry skin (abdominal site) for 30 seconds or moist skin (inguinal site) for 2 minutes.
3M CHG/IPA Surgical Skin Preparation - Abdominal RegionDRUGChlorhexidine gluconate 2% / Isopropyl alcohol 70%
Normal Saline - Abdominal RegionOTHER0.9% sodium chloride applied with foam applicator
3M CHG/IPA Surgical Skin Preparation - Inguinal RegionDRUGChlorhexidine gluconate 2% / Isopropyl alcohol 70%
Normal Saline - Inguinal RegionOTHER0.9% sodium chloride applied with foam applicator
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to N/A
SexMALE
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: * Male subjects of any race who are at least 18 years of age, * Subjects must have an area on their back region to accommodate the treatment coverage area, * Subjects must be in good general health, * Subjects who satisfy all inclusion/exclusion criteria and will voluntarily rea...

Countries:RomaniaUnited States
Unlock Eligibility Criteria

Frequently asked questions about 3M CHG/IPA Surgical Skin Preparation- Abdominal Region

What is 3M CHG/IPA Prep used for?

3M CHG/IPA Prep is an investigational small molecule being studied for bacterial recovery of skin flora post-product application and as a surgical skin preparation. It is in Phase 2 clinical development and is not approved by the FDA.

Who makes 3M CHG/IPA Prep?

3M CHG/IPA Prep is being developed by Solventum Corporation, which trades under the ticker SOLV. The company is conducting clinical trials to evaluate the product's efficacy in skin preparation settings.

What phase is 3M CHG/IPA Prep in?

3M CHG/IPA Prep is in Phase 2 clinical development. Two Phase 2 trials have been completed, and the product remains investigational, meaning it has not received regulatory approval.

What clinical trials is 3M CHG/IPA Prep in?

3M CHG/IPA Prep has been studied in two completed Phase 2 trials: NCT03155178, which enrolled 69 participants to evaluate bacterial recovery of skin flora, and NCT03681990, which enrolled 28 male participants in Romania for surgical skin preparation efficacy.

Is 3M CHG/IPA Prep the same as chlorhexidine and isopropyl alcohol?

3M CHG/IPA Prep is a combination product containing chlorhexidine gluconate (CHG) and isopropyl alcohol (IPA), as indicated by its name. It is being evaluated for its ability to reduce skin bacteria before surgical procedures.